Table 4.
Multivariate analysis of parameters associated with death in patients with cardiovascular disease.
| Characteristics | Model 1 |
Model 2 |
||
|---|---|---|---|---|
| OR (95%CI) | P | OR (95%CI) | P | |
| Age | 1.077 (1.031–1.125) | 0.001 | 1.081 (1.032–1.131) | 0.001 |
| Acute myocardial injury | 5.781 (2.368–14.116) | 0.000 | 7.708 (2.988–19.887) | 0.000 |
| NLR | 1.129 (1.059–1.204) | 0.000 | 1.132 (1.060–1.210) | 0.000 |
| CRP (mg/L) | 1.015 (1.007–1.023) | 0.000 | 1.016 (1.008–1.024) | 0.000 |
| LDH (U/L) | 1.004 (1.001–1.006) | 0.008 | 1.004 (1.001–1.006) | 0.005 |
| β-blockers | 0.255 (0.076–0.853) | 0.026 | ||
| ACEI/ARB | 0.136 (0.035–0.532) | 0.004 | ||
| Arbidol | 0.246 (0.084–0.723) | 0.011 | 0.205 (0.067–0.631) | 0.006 |
| Ribavirin | 0.238 (0.082–0.685) | 0.008 | 0.208 (0.070–0.618) | 0.005 |
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.